UnitedHealth Group (UNH) PT Raised to $171 at Oppenheimer

Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating and raised his price target on UnitedHealth Group (NYSE: UNH) to $171.00 (from $161.00) following its analyst day.

Wiederhorn commented, "UnitedHealth Group issued FY2017 adj. EPS guidance of $9.30-9.60, well ahead of OPCO/Street estimates of $9.20/$9.15. The outlook was boosted by $0.25/sh from the one-year reprieve of the HIF and $0.25 from a reduced Individual/Exchange headwind. Nevertheless, business operations still accounted for 10-14% growth, as robust expected growth in Medicare Advantage dramatically outperformed our estimates. As a result, we are raising our 2017 EPS estimate to $9.43 from $9.20 and our price target to $171 from $161."

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $157.59 yesterday.

You May Also Be Interested In

• Teladoc (TDOC) on Watch, UnitedHealth (UNH) Optum To End Virtual Care Business: Endpoints
• Goldman Sachs Upgrades Akzo Nobel NV (AKZA:NA) (AKZOY) to Neutral
• Jefferies Downgrades Calix (CALX) to Hold